Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/

Press Release

Close Up: genae and the Secret to MedTech Trial Success

Jun 29, 2020

In September 2019, genae joined the IQVIA Healthcare family. genae is a data-driven service provider with a focus on MedTech devices and technologies. In an industry largely focused on pharmaceutical trials, this MedTech capability is unique. We talked to Aly Talen, co-founder of genae & VP MedTech Strategy of IQVIA MedTech, about how its experts can help manage MedTech clinical trials with full-service CRO-support in every phase of the research process.

“Our MedTech expertise goes back to our foundation in 2005,” says Aly Talen, co-founder of genae & VP MedTech Strategy of IQVIA MedTech. “We first mainly worked on cardiovascular implants, but we have since expanded our knowhow to the full range of MedTech technologies, from orthopedics to neurostimulators. Naturally, all these devices require clinical trials as part of their development. However, most clinical trial and contract research organizations focuses on pharmaceuticals. Our specific MedTech expertise is unique. Our team now consists of 100+ professionals, of which about 50 are based in our headquarters in Antwerp.”

A Well-Kept Secret

For a hospital, there are only upsides to participating in a well-run clinical trial, specifically when it comes to clinical trials with novel Medical Devices. Being at the forefront of new technologies, expanded treatment options, the opportunity to become a leader and expert in a specific technology, and networking and development opportunities is not only important for the clinicians involved, but also for the reputation of the hospital.

The Challenge of Enrollment

genae, now IQVIA MedTech, can take care of the Regulatory Strategy, the study document creation compliant to the Medical Device Regulations, the site selection, the submission to the Medical Device Unit of the FAGG/AFMPS, and the overall set-up and execution of the clinical trial. “Our biggest challenge is enrollment, finding the right doctors and patients for trials,” says Talen. “Hospitals with a strong patient cohort selection for clinical trials definitely have the advantage. Usually, this is a result of a having a strong research advocate within the hospital. But software solutions such as the Forcea HealthReport Clinical module, and the effective and efficient patient identification and selection they allow, make a hospital’s decision to participate easier as well. Searching through medical records is a laborious and time-consuming process. Solutions such as Forcea HealthReport Clinical and its intelligent search engine makes the required information instantly available.”

The Impact of MDR/IVDR

One of the hottest topics in the MedTech world is the European Medical Devices Regulation/In-vitro Diagnostics Regulation (MDR/IVDR). Due to COVID-19, the MDR has been postponed with one year and will come into effect in May 2021, IVDR will follow in May 2024. The new regulations include expanded clinical evidence requirements and it will impact the industry significantly. “80% of the IVDs used to fall under self-certification. Only 7% will remain self-certified; the rest must be certified by notified bodies,” says Talen. “Due to the limited number of notified bodies, we’re expecting a certification bottleneck. At the same, stricter clinical evidence requirements means strong research partnerships with the industry and hospitals will become even more important. Either way, we’re ready to be the knowledgeable partner who can guide all our stakeholders through the clinical process as smoothly as possible.”

Contact Us